North American sales a "vote of confidence" in new
technologies, approach
GUELPH,
ON, June 7, 2022 /CNW/ - BIOREM Inc. (TSXV:
BRM) ("Biorem" or "the Company") today announced $11-million of new orders for air emission
abatement projects in North America. This brought the
company's order backlog to a record $40-million, its highest point since the company
was founded in 1990.
"These recent orders are a vote of confidence in our newer
technologies in the air emissions area," said Derek S. Webb, President and Chief Executive
Officer. "The bulk of the new orders, $7-million, are for two of our latest product
releases and represent a significant expansion of our North
American odor and hazardous gas emissions abatement businesses."
The new products were introduced to a carefully-selected trial
market segment that accounts for approximately 1/3 of the potential
North American market. This positive initial customer
response bodes well for markets outside the test area, as the
company's sales network will begin marketing them to other domestic
and global customers in the coming months.
"BIOREM was able to win these orders despite increased
competitive pressure," added Webb. "All of these projects met
with significant competitive resistance but customers chose our
solutions because of their performance – and we expect a similar
response as we introduce these products to customers in other parts
of the world."
BIOREM's engineering and product development groups spent
considerable time during the pandemic lockdowns of 2020 and 2021
designing the next generation of the company's emissions abatement
equipment, supplementing the firm's traditional biological
filtration products with those using the next generation of
physical technologies. The new products include a consumable
component that is expected to generate recurring revenues as the
equipment ages and the adsorbents are consumed. This is
expected to broaden BIOREM's revenue base and growth potential as
it expands its service offerings.
About the North American Air
Emissions Market
The air emissions abatement market in North America is currently growing at an
annualized rate of 5.4% and expected to be at $1.6B (USD) by 2027. The technologies
servicing this market are divided into biological (30%), physical
(40%) and chemical (30%)
About Biological
Technologies
Biological reactors use a variety of microorganisms, from
bacteria to mold and fungi to destroy hazardous air
pollutants. Essentially, these microorganisms utilize the air
pollutants as a food source, degrading them to harmless by-products
such as carbon dioxide and water vapour. BIOREM's unique
engineered media provide reliable performance over a useful life of
two or more decades, resulting in extremely low operating costs for
customers.
About Physical
Technologies
Physical treatment solutions in the context of gaseous phase
pollutant abatement is typically used to describe the use of
adsorbents to remove the contaminant from the gas stream.
Specialty material like activated carbon, zeolite or other more
advanced engineered media are used to absorb/adsorb the hazardous
pollutant on the surface or within the pore structure of the
media. Once all available attachment spaces are utilized, the
media is considered 'spent' and must be replaced.
About BIOREM Inc.
BIOREM is a leading clean technology company that designs,
manufactures and distributes a comprehensive line of
high-efficiency air emissions control systems used to eliminate
odors, volatile organic compounds (VOCs), and hazardous air
pollutants (HAPs). With sales and manufacturing offices across the
continent, a dedicated research facility, a worldwide sales
representative network and more than 2000 installed systems
worldwide, BIOREM offers state-of-the-art technology-based products
and peace of mind for municipalities, industrial companies and
their surrounding communities. Additional information on Biorem is
available on our website at www.biorem.biz.
View original
content:https://www.prnewswire.com/news-releases/biorem-order-backlog-grows-to-40-million-on-strength-of-11-million-in-new-orders-301562831.html
SOURCE Biorem Inc.